Skip to main content

Table 2 Clinical manifestations of patients with methanol intoxication, stratified according to status of renal damage as AKI or non-AKI (n = 50)

From: Acute kidney injury and the risk of mortality in patients with methanol intoxication

Variable AKI patients
(n = 33)
Non-AKI patients
(n = 17)
All patients
(N = 50)
P value
Latent period, hours 6.9 ± 13.2 2.4 ± 6.0 5.3 ± 11.4 0.191
Hypothermia, n (%) 12 (36.4) 3 (17.6) 15 (30.0) 0.171
Hypotension, n (%) 13 (39.4) 3 (17.6) 16 (32.0) 0.118
Bradycardia, n (%) 5 (15.2) 2 (11.8) 7 (14.0) 0.744
Blurred vision, n (%) 11 (33.3) 5 (29.4) 16 (32.0) 0.778
Blindness, n (%) 5 (15.2) 0 (0) 5 (10.0) 0.091
Photophobia, n (%) 1 (3.0) 1 (5.9) 2 (4.0) 0.626
Mydriasis, n (%) 5 (15.2) 1 (5.9) 6 (12.0) 0.339
Dyspnoea, n (%) 25 (75.8) 5 (29.4) 30 (60.0) 0.002**
Acute respiratory failure, n (%) 21 (63.6) 5 (29.4) 26 (52.0) 0.022*
Nausea/vomiting, n (%) 14 (42.4) 7 (41.2) 21 (42.0) 0.933
Gastrointestinal bleeding, n (%) 12 (36.4) 4 (23.5) 16 (32.0) 0.357
Abdominal pain, n (%) 10 (30.3) 3 (17.6) 13 (26.0) 0.334
Pancreatitis, n (%) 4 (12.1) 0 (0) 4 (8.0) 0.134
Hepatitis, n (%) 2 (6.1) 0 (0) 2 (4.0) 0.300
Glasgow coma scale score 9.5 ± 5.5 11.8 ± 5.2 10.3 ± 5.5 0.170
Deep coma, n (%) 14 (42.4) 4 (23.5) 18 (36.0) 0.187
  1. *P < 0.05 and **P < 0.01